Hostname: page-component-54dcc4c588-sq2k7 Total loading time: 0 Render date: 2025-10-10T10:49:18.509Z Has data issue: false hasContentIssue false

Effectiveness of a community-based, multicomponent and case managed treatment for patients with severe schizophrenia

Published online by Cambridge University Press:  26 August 2025

J. J. Fernández-Miranda*
Affiliation:
AGCSM V- Hospital de Cabueñes, SESPA, Gijón
S. Díaz-Fernández
Affiliation:
AGCSM V- Hospital de Cabueñes, SESPA, Gijón
F. López-Muñoz
Affiliation:
Health Sciencies, Universidad Camilo J. Cela, Madrid, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Case management is a model of community intervention in people with severe mental illness.

Objectives

To explore the treatment adherence and effectiveness of patients with severe schizophrenia undergoing treatment in a community-based, case management program (CMP) with an integrated pharmacological and psychosocial approach compared to the standard treatment.

Methods

An observational, longitudinal study was conducted with a ten-year follow-up of patients with severe schizophrenia (CGI-S ≥ 5) treated in mental health units (MHUs) or on a CMP (N = 688). All causes of treatment discontinuation, psychiatric hospital admissions, suicide attempts, and antipsychotic (AP) medications were recorded. Clinical severity was assessed with the CGI-S.

Results

Adherence to the CMP was higher than to the standard treatment (p < 0.001). There were fewer hospital admissions and suicide attempts on the CMP than in standard care (p < 0.001). Clinical severity decreased more in the CMP than in MHUs (p < 0.005). Long-acting injectable (LAI) AP medication was more closely related to these outcomes than oral APs (p < 0.001) in both settings, but especially on the CMP.

Treatment clinical outcomes after 10-year follow-up

N = 688Mental Health Units (N = 344)Case Management Program (N = 344)χ 2; P value
Treatment discontinuation (N (%))150 (43.6)42 (12.1)26.16; < 0.0001
CGI-S (Av (SD))3.9 (1.1)3.1 (0.9)7.63; < 0.005
Hospitalization (N (% ))160 (46.5)60 (17.4)10.54; < 0.0001
Hospitalization (Av (SD))3.2 (3.4)0.9 (0.3)13.23; < 0.0001
Involuntary hospital. (N (% ))34 (9.9)5 (1.4)28.01; < 0.0001
Involuntary hospital. (Av (SD))0.5 (0.3)0.01 (0.2)21.31; < 0.0001
Suicide attempt (N (%))85 (24.7)20 (5.8)10.54; < 0.0001
Num. suicide attempts (Av (SD))0.3 (0.1)0.07 (0.02)11.32; < 0.0001

N: number of patients %: percentage of patients Av: average SD: standard deviation

*: basal (at beginning of program) **: standard treatment ***: Program treatment

Conclusions

The treatment of patients with severe schizophrenia in a multicomponent, case-managed program recorded higher compliance and effectiveness compared to standard care. Treatment with LAI antipsychotics was linked to these outcomes. A combination of case management, psychosocial approach, and LAI AP medication contributed more to the achievement of clinical goals in these patients than the standard treatment and oral APs.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.